Driehaus Capital Management LLC Dexcom Inc Transaction History

Driehaus Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $59,183 - $73,108	-698 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $82,992 - $111,188	-1,064 Reduced 60.39%	698 $258,000
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $20,439 - $24,171	214 Added 13.82%	1,762 $726,000
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $5,390 - $9,059	86 Added 5.88%	1,548 $628,000
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $10,179 - $16,109	-213 Reduced 12.72%	1,462 $394,000
Q4 2019 Feb 12, 2020	BUY	$36.62 - $57.29 $146 - $229	4 Added 0.24%	1,675 $366,000
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $59,370 - $73,189	1,671 New	1,671 $249,000
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $92,150 - $128,825	-3,310 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $43,396 - $59,026	1,546 Added 87.64%	3,310 $394,000
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $134,248 - $185,878	-4,974 Reduced 73.82%	1,764 $211,000
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $157,332 - $247,419	6,738 New	6,738 $964,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.